Table 3.

Primary outcome measures: number of patients achieving an ACR20 and 35% improvement in patient GA

Consultation-type allocation	Consultation			No consultation
Medication-type allocation	Individual	Complex	Placebo	Complex	Placebo
Treatment group allocation	1	2	3	4	5
No. of completers	16	14	16	15	16
No. of completers who achieved ACR20, n (%)	5 (31.3)	2 (14.3)	5 (31.2)	2 (13.3)	2 (12.5)
No. of completers who achieved 35% patient GA, n (%)	6 (37.5)	6 (42.9)	6 (37.5)	4 (26.7)	6 (37.5)